CHEMOTHERAPY DRUGS
Dr Reddy's, Sun Pharma recall drugs in US market: USFDA
Dr Reddy's Laboratories and Sun Pharma are recalling products in the US due to manufacturing issues, as per the latest USFDA Enforcement Report. Dr Reddy's is recalling insomnia and gout drugs, with 13,752 bottles of Eszopiclone tablets affected by failed impurities at their Bachupally plant. Sun Pharma is recalling 2,088 vials of Decitabine for Injection due to CGMP deviations at their Gujarat plant, prompting Class II recalls by both companies.
Wockhardt soars to 6-year high
Wockhardt's stock soared 20% as Zaynich antibiotic treated a US cancer patient with Pseudomonas infection at Children's Hospital of Orange County. The drug's success enabled chemotherapy, highlighting its potential impact on cancer deaths and Wockhardt's financial outlook.
DCGI orders withdrawal of cancer drug Olaparib for certain treatments
The Drug Controller General of India has requested the withdrawal of AstraZeneca's Olaparib tablets for certain cancer treatments due to potential adverse effects.
Regulator asks state bodies to limit scope of key cancer drug
India's drug regulatory authority has instructed state-level counterparts to mandate manufacturers of Olaparib tablets in 100 mg and 150 mg strengths to cease marketing the cancer medication for patients with advanced ovarian cancer and "gBRCA mutation" (genes associated with tumor suppression), who have undergone three or more rounds of prior chemotherapy treatment.
ED raids 10 locations in Delhi-NCR in fake cancer drugs investigation
The Enforcement Directorate conducted raids in Delhi-NCR as part of a money laundering investigation linked to a fake cancer drugs racket. The operation, tied to an organised criminal group, involved manufacturing and selling counterfeit cancer and chemotherapy drugs. Authorities recovered about Rs 65 lakh in cash from two locations and are pursuing legal action against the perpetrators.
Delhi police busts fake cancer drug racket: Here's how they sold Rs 100 drug for Rs 2 lakh
The Delhi Police have uncovered a massive fake drug operation in west Delhi’s Moti Nagar, involving the manufacturing and distribution of fake cancer and chemotherapy drugs. The accused allegedly filled empty vials with anti-fungal medicine worth ₹ 100 and sold them as "life-saving" cancer drugs across India, China, and the US for ₹ 1 to 3 lakh per vial. The operation, masterminded by Viphil Jain from Baghpat, lasted over two years, with more than 7,000 such injections sold. Seven individuals, including Suraj from West Bengal, have been arrested, and legal action is underway.
- Go To Page 1
Yellapragada Subbarow: How one Indian revolutionised cancer treatment
World Cancer Day: World Cancer Day is a global observance dedicated to raising awareness about cancer, encouraging its prevention, detection, and treatment, and highlighting the need for increased support in the battle against this formidable disease. Marked on February 4th each year, World Cancer Day unites individuals, communities, and organisations worldwide in the common goal of addressing the challenges posed by cancer and working towards a future where its impact is significantly reduced.
Immunotherapy can stall the growth of malignant cells in cervical cancer patients: Study
In India, cervical cancer is the second most common in women, making up close to 18 per cent of the new cancer cases, the International Agency for Research on Cancer (IARC), WHO's cancer agency has estimated.
Ovarian cancer can metastasize rapidly in elderly patients: Study
The researchers used a chemotherapy-induced senescent model to study this phenomenon, Bengaluru-based IISc said in a press release.
Zydus Lifesciences gets USFDA nod for generic cancer treatment capsules
Zydus Lifesciences Ltd has received final approval from the USFDA for its generic version of the cancer treatment drug Cyclophosphamide capsules. The approval covers strengths of 25 mg and 50 mg.
Venus Remedies gets marketing authorisation from Philippines, Saudi Arabia for three oncology drugs
Pharma major Venus Remedies on Wednesday said it has received marketing authorisation from Philippines and Saudi Arabia for three oncology drugs. In a statement, the Panchkula-based company said it has received regulatory approval from Philippines, the second largest market in the Association of Southeast Asian Nations (ASEAN) region, for chemotherapy drug paclitaxel and zoledronic acid.
Venus Remedies gets marketing approval for six chemotherapy drugs from Philippines
Venus Remedies has already submitted dossiers to the Health Ministry of the Philippines for additional 45 marketing authorisations, and most of these pending approvals are for oncology products, it said. Pertinently, the market size of cancer drugs in the Philippines was valued at USD 252 million in 2020 and is expected to grow at a compound annual growth rate of 8.7 per cent by 2025.
Jill Martin's double Mastectomy Successful in her battle against breast cancer, but chemotherapy looms ahead
Jill Martin, a contributor to the "Today" show, underwent a double mastectomy, which was deemed a "successful" procedure.
Venus Remedies gets marketing authorization from Saudi Arabia for chemotherapy drug Docetaxel
The development comes three months after the company received good manufacturing practices (GMP) certification from the Saudi Food and Drug Authority (SFDA) for all its production facilities at its unit in Baddi, Himachal Pradesh.
View: India's drug industry needs a major overhaul
Despite campaigns for regulatory reform since a corruption and fraud scandal in 2013, India's Central Drugs Standard Control Organisation remains unreformed, and a law on drug recalls has been under discussion since 1976 without resolution. Experts call for overhaul, transparency, and accountability to ensure safer manufacturing and export practices.
New drug can be the answer to high child mortality rates: Study
A new drug called CADD522 will block a gene associated with bone cancer, according to researchers.
AstraZeneca gets CDSCO nod for drug to treat biliary tract cancer
Drug firm AstraZeneca India on Friday said it has received approval from the domestic drug regulator to market a drug to treat biliary tract cancer (BTC) in the country. The company has received approval from the Central Drugs Standard Control Organisation (CDSCO) for Durvalumab, the drug firm said in a statement.
Glenmark introduces medication to prevent chemotherapy-induced nausea
The company has introduced IV injection formulation Akynzeo IV in a fixed dose combination of fosnetupitant (235 mg) and palonosetron (0.25 mg) and is available as a ready-to-dilute IV injection, the Mumbai-based drug maker said in a statement.
What time you take your medications matters! Your circadian rhythm influences how well treatments work
Many drug targets in the body follow a 24-hour cycle.
Aurobindo unit, Evive Biotech ink licensing pact to commercialise CIN treatment product in US
Neutropenia is a common side-effect of chemotherapy and is a condition characterised by low levels of neutrophils, a type of white blood cell that fights infection. The licensing pact has been inked between Evive and Acrotech Biopharma (Acrotech), a New Jersey-based and wholly-owned subsidiary of Aurobindo Pharma USA Inc, Aurobindo Pharma said in a statement.
Alembic Pharma gets USFDA nod for generic injection to treat cancer
The approval granted by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for Paclitaxel injection of strengths 30 mg/5 mL (6 mg/mL), 100 mg/16.7 mL (6 mg/mL), and 300 mg/50 mL (6 mg/mL) multiple-dose vials.
AstraZeneca India receives DCGI's nod to market drug treating breast cancer
The Drugs Controller General of India (DCGI) has approved Lynparza (Olaparib) as a monotherapy for the treatment of adult patients with early breast cancer, who have previously been treated with neoadjuvant or adjuvant chemotherapy.
New test can tell how much immunity you have against COVID-19
US researchers have developed an easy-to-use test that can predict the degree of immune protection people have against COVID-19, either from vaccination, infection, or a combination of the two.
Drug discovery gaps can only be filled by returning to the root of medicine, says this scientist
Natural products from microbes and plants are the biggest resource for drug discovery.
'Unheard-of' cancer drug trials slow tumor growth, extend life of patients
The new study would change how medicine was practiced, cancer specialists said.
Roche Pharma launches drug to treat breast cancer
PHESGO was first approved by the US FDA in June 2020 during the peak of the Covid pandemic, by the European Medicines Agency (EMA) in December 2020. In India, PHESGO was approved by the DCGI in October 2021 and the import license was granted in January 2022. Globally, over 17,000 breast cancer patients have benefitted from PHESGO as on December 2021, the drug firm stated.
Cancer treatment without Chemotherapy? Here is how it could be possible
Chemotherapy for decades was considered “the rule, the dogma,” for treating cancer, but various data offer some confirmation that the method is on the wane for many cancer patients.
Chemotherapy drug outperforms remdesivir against coronavirus in lab experiments: Study
Using this hybrid approach, scientists from the Shenzhen Institutes of Advanced Technology in China, screened 1,906 existing drugs for their potential ability to inhibit replication of the coronavirus by targeting a viral protein called RNA-dependent RNA polymerase (RdRP).
This drug may replace chemotherapy, redefine cancer care
These drugs will attack cancer cells in the body without damaging surrounding healthy ones.
Load More
